| Clinical data | |
|---|---|
| Other names | 1-(Thiophene-2-carbonyl)-LSD; SYN-L-021 |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C25H27N3O2S |
| Molar mass | 433.57 g·mol−1 |
| 3D model (JSmol) | |
| |
1T-LSD, also known as 1-(thiophene-2-carbonyl)-LSD or as SYN-L-021, is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.12 It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead.3 It was also detected in Germany around the same time.4
Use and effects
A 150 μg dose of 1T-LSD is said to be equivalent to 100 μg LSD.2 Doses of 87 to 100 μg 1T-LSD have been encountered in blotter tabs.1
Interactions
Chemistry
Analogues
Analogues of 1T-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1V-LSD, 1DD-LSD, and 1T-AL-LAD, among others.
Society and culture
Legal status
Canada
1T-LSD is not a controlled substance in Canada as of 2025.5
United States
1T-LSD is not an explicitly controlled substance in the United States.6 However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
References
References
- "1T-LSD". АИПСИН (in Russian). 21 August 2023. Retrieved 1 January 2026.
- "1T-LSD". АИПСИН (in Russian). Retrieved 1 January 2026.
- Okada Y, Ueno K, Nishiwaki N, Nishimura T, Segawa H, Yamamuro T, et al. (July 2023). "Identification of 1-(thiophene-2-carbonyl)-LSD from blotter paper falsely labeled "1D-LSD"". Forensic Toxicology. 42 (1): 93–101. doi:10.1007/s11419-023-00668-8. PMID 37421500. S2CID 259374662.
- "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
- "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
- Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026